These experiments revealed a significant increase in SIX1 (3-fold), EYA1 (4-fold), and EYA2 (3-fold) transcript levels in IPF but not in COPD or controls (Figure 1, A–C). This evidence concerns the gene EYA1 and chronic obstructive pulmonary disease.